Screening for retinopathy of prematurity in North China
- PMID: 35668518
- PMCID: PMC9169323
- DOI: 10.1186/s12886-022-02470-3
Screening for retinopathy of prematurity in North China
Abstract
Purpose: To analyze the incidence and severity of retinopathy of prematurity (ROP) in north China, and to evaluate the effectiveness of different ROP screening criteria.
Patients and methods: The screening data of premature infants were collected from 2016 to 2021. The severity of ROP was graded according to the International Classification of Retinopathy of Prematurity (2005). And the treatment for ROP followed the Early Treatment for Retinopathy of Prematurity Cooperative Group. The effects of gestational age (GA) and birth weight (BW) on the incidence and severity of ROP were evaluated. The screening data were also analyzed using different ROP screening guidelines.
Results: A total of 4069 infants underwent ROP screening, and 728 infants (17.9%) were diagnosed with ROP. Of those, 78 infants (1.9%) received treatments. Gestational age and BW showed significant differences between infants with and without ROP (29.1 ± 2.1w vs. 32.9 ± 2.6w, p < 0.001; 1362.7 ± 427.3 g vs. 1751.9 ± 509.4 g, p < 0.001; respectively). Fifty-six infants (7.69%), 188 infants (25.82%), and 104 infants (14.29%) in all infants with ROP would have been missed according to the China, USA, and UK screening guidelines respectively. If GA ≤ 33 weeks and/or BW ≤ 2100 g were considered as screening criteria, only one infant (0.14%) with critical systemic illness was missed diagnosed with severe ROP.
Conclusion: Gestational age and BW are major risk factors for the incidence and severity of ROP. And the incidence and treatment rate of ROP in Tianjin is similar to that reported in the other regions of China. Modified ROP screening criteria were considered to be more effective in Tianjin.
Keywords: Birth weight; Gestational age; Retinopathy of prematurity; Screening criteria.
© 2022. The Author(s).
Conflict of interest statement
No authors have any financial/conflicting interests to disclose.
Figures
Similar articles
-
Screening for retinopathy of prematurity in China: a neonatal units-based prospective study.Invest Ophthalmol Vis Sci. 2013 Dec 19;54(13):8229-36. doi: 10.1167/iovs.13-12297. Invest Ophthalmol Vis Sci. 2013. PMID: 24204053
-
Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study.JAMA Ophthalmol. 2018 Sep 1;136(9):1034-1040. doi: 10.1001/jamaophthalmol.2018.2753. JAMA Ophthalmol. 2018. PMID: 30003216 Free PMC article.
-
Retinopathy of prematurity: are we missing any infant with retinopathy of prematurity?Br J Ophthalmol. 2012 Aug;96(8):1052-5. doi: 10.1136/bjophthalmol-2012-301570. Epub 2012 May 30. Br J Ophthalmol. 2012. PMID: 22649086
-
Demographic Risk Factors of Retinopathy of Prematurity: A Systematic Review of Population-Based Studies.Neonatology. 2022;119(2):151-163. doi: 10.1159/000519635. Epub 2022 Feb 4. Neonatology. 2022. PMID: 35124682
-
Current update on retinopathy of prematurity: screening and treatment.Curr Opin Pediatr. 2011 Apr;23(2):173-8. doi: 10.1097/MOP.0b013e3283423f35. Curr Opin Pediatr. 2011. PMID: 21150442 Free PMC article. Review.
Cited by
-
Editorial to the Special Issue "Retinopathies: A Challenge for Early Diagnosis, Innovative Treatments, and Reliable Follow-Up".Medicina (Kaunas). 2025 Apr 3;61(4):662. doi: 10.3390/medicina61040662. Medicina (Kaunas). 2025. PMID: 40282953 Free PMC article.
-
Multi-omics integration identifies key biomarkers in retinopathy of prematurity through 16S rRNA sequencing and metabolomics.Front Microbiol. 2025 Jun 18;16:1601292. doi: 10.3389/fmicb.2025.1601292. eCollection 2025. Front Microbiol. 2025. PMID: 40606147 Free PMC article.
-
Epidemiology and distribution of 207 rare diseases in China: A systematic literature review.Intractable Rare Dis Res. 2024 May 31;13(2):73-88. doi: 10.5582/irdr.2024.01001. Intractable Rare Dis Res. 2024. PMID: 38836174 Free PMC article. Review.
-
Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers.BMC Ophthalmol. 2025 Jan 3;25(1):3. doi: 10.1186/s12886-024-03836-5. BMC Ophthalmol. 2025. PMID: 39754098 Free PMC article.
-
Clinical effects of the 2021 update of the Turkish retinopathy of prematurity guideline.BMC Ophthalmol. 2025 Jul 1;25(1):360. doi: 10.1186/s12886-025-04182-w. BMC Ophthalmol. 2025. PMID: 40598074 Free PMC article.
References
-
- Zhu JF, Zou HD, He XG, et al. Cross-sectional investigation of visual impairing diseases in Shanghai blind children school. Chin Med J (Engl) 2012;125:3654–3659. - PubMed
-
- Li XX. Chinese Ophthalmological Society Fundus Diseases Group. Screening guidelines of retinopathy of prematurity in China (2014) Chin J Ophthalmol. 2014;50(12):933–5.
-
- Fierson WM. American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018;142(6):e20183061. doi: 10.1542/peds.2018-3061. - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources